Edition of 20 October 2026
As of the edition of 20 October 2026, the list holds 17,976 drugs, 905 of them with a US protection year, and 114 with US protection ending within two years.
What this edition holds
| Count | This edition |
|---|---|
| Drugs with a record | 17,976 |
| Marketed drugs | 3,542 |
| Drugs with a US protection year | 905 |
| Drugs with US protection still running | 699 |
| US protection ending within two years | 114 |
| US protection ending within four years | 221 |
| Companies | 2,274 |
| Targets | 1,259 |
| Company-target rows on route A | 2,799 |
| Company-target rows on route B | 2,016 |
US protection movers
This is the first edition on record, so there is nothing yet to compare it with. The next edition will list the drugs that entered or left the two-year window.